Literature DB >> 7015005

Distribution of carcinoembryonic antigens and blood group substances in adenocarcinoma of the colon.

E L Wiley, G Mendelsohn, J C Eggleston.   

Abstract

Immunoperoxidase techniques were used to localize carcinoembryonic antigens (CEA) and human blood group substances (BGS) in 41 adenocarcinomas of the colon and 15 metastases or recurrences of these tumors. Ten primary tumors (24 per cent) were strongly positive for both antigens, 12 (29 per cent) were positive for BGS only, 11 (27 per cent) were positive for CEA only, and eight (20 per cent) contained only microscopic amounts of either. With few exceptions, individual tumor cells contained either CEA, BGS, or neither, but not both. Cancers of the left colon which were positive for BGS were associated with a lower frequency of metastases than were those without BGS (p less than 0.01); tumors lacking both CEA and BGS metastasized more frequently than those tumors containing either or both antigens (p less than 0.01). In tumors of the right colon, there was no significant correlation between antigen content and frequency of metastases. In three cases, the development of recurrent or metastatic tumor was associated with a loss of BGS positivity. The data suggest that immunohistochemical studies of BGS and CEA may be of value in estimating the clinical behavior of certain colon carcinomas.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7015005

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  13 in total

Review 1.  Perspectives on the significance of altered glycosylation of glycoproteins in cancer.

Authors:  Y J Kim; A Varki
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

2.  The expression of colorectal carcinoma-associated antigens in the normal colonic mucosa. An immunohistochemical analysis of regional distribution.

Authors:  B C Wolf; R R Salem; H F Sears; D A Horst; P T Lavin; M Herlyn; S H Itzkowitz; J Schlom; G D Steele
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

3.  Regional distribution of glycoconjugates in normal, transitional and neoplastic human colonic mucosa. A histochemical study using lectins.

Authors:  J Calderó; E Campo; C Ascaso; J Ramos; M J Panadés; J M Reñé
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

4.  A metastasis-associated antigen is present on a 60 kDa glycoprotein in transitional cell carcinoma of the human urinary bladder.

Authors:  T Matsusako; H Muramatsu; T Shirahama; T Muramatsu; Y Ohi
Journal:  Histochem J       Date:  1992-11

5.  Monoclonal antibody localization of A and B isoantigens in normal and malignant fixed human tissues.

Authors:  C Ernst; J Thurin; B Atkinson; H Wurzel; M Herlyn; N Stromberg; C Civin; H Koprowski
Journal:  Am J Pathol       Date:  1984-12       Impact factor: 4.307

6.  Immunohistochemical study of blood group activities in the alimentary canal in normal and pathologic conditions with reference to the nature of epithelial mucopolysaccharides.

Authors:  T Ohshima; H Maeda; N Tanaka; T Nagano
Journal:  Z Rechtsmed       Date:  1988

7.  Heterogeneous expression of two oncodevelopmental antigens, CEA and SSEA-1, in colorectal cancer.

Authors:  S H Itzkowitz; Z R Shi; Y S Kim
Journal:  Histochem J       Date:  1986-04

8.  Biological tissue markers in benign and malignant disease of the human prostate.

Authors:  P Chastonay; J Hurlimann; D Gardiol
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

9.  Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase.

Authors:  E Heyderman; B M Brown; T C Richardson
Journal:  J Clin Pathol       Date:  1984-12       Impact factor: 3.411

10.  High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomas.

Authors:  Zahra Madjd; Tina Parsons; Nicholas F S Watson; Ian Spendlove; Ian Ellis; Lindy G Durrant
Journal:  Breast Cancer Res       Date:  2005-07-28       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.